TENA's dominance in the European adult incontinence market is undeniable—the Swedish brand commands approximately 28% market share and has become virtually synonymous with the category itself. Yet for distributors, this market leadership comes with a significant trade-off: compressed margins that make it increasingly difficult to build profitable, sustainable businesses. As the wholesale adult incontinence market continues its projected growth toward €8.2 billion by 2028, savvy distributors are exploring TENA alternatives that deliver comparable quality with substantially better financial returns.
The TENA Margin Challenge: Why Distributors Are Looking Elsewhere
TENA's market position allows the brand to maintain strict pricing structures that typically leave distributors with margins in the 18-22% range—well below the 30-40% margins common in other healthcare product categories. This margin compression becomes particularly acute when distributors factor in the operational costs of handling bulky incontinence products: warehouse space, logistics, customer service, and marketing support all erode profitability further.
The challenge intensifies in competitive retail environments where TENA's widespread availability—from pharmacies to supermarkets to Amazon—creates constant price pressure. Distributors find themselves competing not just with each other but with direct-to-consumer channels that can undercut wholesale pricing. Meanwhile, TENA's minimum order quantities and payment terms can strain working capital, especially for mid-sized distributors looking to expand their portfolios without excessive inventory risk.
What Makes a Viable TENA Competitor for Wholesale Distribution
Not all adult diaper alternatives offer genuine commercial advantages. Distributors evaluating TENA competitors should assess candidates across several critical dimensions that directly impact profitability and market acceptance:
Manufacturing Standards and Certification
CE certification is non-negotiable for European distribution, but the manufacturing location matters significantly. Products manufactured within the EU typically offer faster replenishment cycles, lower freight costs, and reduced customs complexity compared to Asian imports. Belgium, France, and Germany have established themselves as centers of excellence for incontinence product manufacturing, combining advanced production technology with stringent quality control.
Product Performance Metrics
Absorption capacity remains the fundamental performance indicator. Competitive alternatives should offer absorption levels of at least 2,500ml for day products and 3,400ml+ for overnight solutions—matching or exceeding TENA's specifications. The SAP (Super Absorbent Polymer) core technology, barrier leak guards, and skin-friendly materials determine whether a product can genuinely compete on performance rather than price alone.
Supply Chain Flexibility
Multi-warehouse distribution across Europe significantly reduces delivery times and freight costs. Brands offering warehousing in Western Europe (Belgium, France, Netherlands) and Southern Europe (Greece, Italy) provide distributors with better responsiveness to market demand and the ability to consolidate orders across product lines. This logistics advantage can translate to 7-10% cost savings compared to single-point distribution models.
Commercial Terms That Support Growth
The most distributor-friendly brands structure their commercial terms to support market development: reasonable minimum order quantities (typically one container quarterly rather than monthly), payment terms that don't strain working capital, and meaningful volume incentives that reward growth. Free goods programs—particularly for new distributor onboarding—reduce the financial risk of introducing a new brand to the market.
KERA: A European Alternative Built for Distributor Success
Among the TENA alternatives gaining traction in European wholesale channels, KERA represents a particularly compelling option for distributors prioritizing both quality and margin optimization. As a brand directly owned by its founder and distributed through EASYCARE IKE in Athens, KERA eliminates the corporate layers that typically erode distributor profitability.
The brand's manufacturing strategy leverages specialized facilities across three EU countries: pull-up pants from Belgium's advanced production lines, tape-style diapers from Greek facilities with strong cost-efficiency, and underpads from French manufacturers known for technical innovation. This diversified approach ensures product availability while maintaining the quality standards expected in healthcare distribution.
Product Range and Unique Market Positioning
KERA's product portfolio covers the full spectrum of adult incontinence needs, from light bladder control pads (400ml absorption) through heavy overnight protection (4,300ml absorption). The product architecture deliberately targets the volume segments where TENA dominates: moderate-to-heavy incontinence for institutional and retail distribution.
A notable competitive advantage lies in KERA Bed underpads, particularly the 75x90cm size format. This dimension precisely fits standard hospital beds and care facility mattresses—a specification that most competitors, including TENA, don't offer in their standard ranges. For distributors serving healthcare institutions, this unique sizing addresses a genuine market gap and reduces competitive pressure.
Commercial Structure Designed for Distributors
KERA's distributor program addresses many of the friction points that make TENA challenging for growth-oriented wholesalers. The minimum order quantity of one 40-foot high-cube container per quarter provides meaningful volume without the inventory burden of monthly commitments. Payment terms of 30% deposit with 70% before loading balance supplier risk management with distributor cash flow needs.
New distributors receive a 5% free goods bonus during their first six months—effectively a margin enhancement that supports initial market development and promotional activities. Perhaps more significantly, KERA offers exclusive territory agreements with 12-month renewable terms, providing distributors with genuine market protection rather than competing against unlimited parallel distribution in the same geography.
Financial Analysis: Margin Comparison Across TENA Alternatives
When distributors conduct rigorous financial modeling comparing TENA with alternatives like KERA, several margin advantages become apparent. Starting with acquisition cost: TENA's wholesale pricing typically ranges from €0.85-1.20 per unit for pull-up pants (depending on volume and territory). Comparable alternatives from European manufacturers typically price 15-25% lower at €0.65-0.95 per unit for equivalent specifications.
This pricing differential flows directly to gross margin. A distributor selling at €1.50 retail (competitive with TENA pricing) achieves a 37-42% gross margin with alternative brands compared to 25-28% with TENA. Over a container volume of 100,000 units annually, this margin differential translates to approximately €15,000-20,000 in additional gross profit—enough to fund significant market development activities or simply improve bottom-line returns.
The margin advantage extends beyond acquisition pricing. Brands offering multi-warehouse European distribution reduce freight costs by 20-30% compared to centralized distribution. Free goods programs effectively enhance margins by 5% during critical market entry phases. And territory exclusivity eliminates the margin-eroding price wars that occur when multiple distributors compete for the same retail accounts with identical TENA products.
Market Positioning Strategy: Competing with TENA Without Direct Confrontation
Successfully distributing a TENA alternative requires strategic positioning that emphasizes value rather than initiating price wars. The most effective distributor strategies focus on underserved market segments where TENA's broad-market positioning creates opportunities:
Healthcare Institutions: Care facilities, rehabilitation centers, and hospitals often welcome qualified alternatives that deliver clinical performance with better pricing. The procurement process emphasizes specifications, certification, and reliability—factors where alternatives like KERA compete effectively. The unique 75x90cm underpad size addresses a genuine institutional need that TENA's standard range overlooks.
Independent Pharmacy Chains: Smaller pharmacy groups increasingly seek differentiation from major chains that stock identical TENA products. Private-label-style partnerships with quality European brands allow these pharmacies to offer value alternatives while maintaining margin structure. The key is supporting pharmacists with clinical information that builds confidence in recommending alternatives.
Online Retail and Marketplaces: Amazon, specialized healthcare e-commerce, and direct-to-consumer channels reward brands that offer compelling value propositions. Products positioned as "premium European quality at accessible pricing" resonate with cost-conscious consumers who understand that brand premiums don't always correlate with performance differences.
Operational Considerations for Distributors
Introducing a TENA alternative into an existing distribution operation requires thoughtful planning around several operational dimensions. Inventory management becomes more complex with multiple brands, requiring clear SKU differentiation and stock rotation protocols. Most distributors find that maintaining 8-12 weeks of inventory provides adequate service levels while avoiding excess working capital tie-up.
Sales team training proves critical—representatives must understand both the clinical specifications and the commercial value proposition. The most successful distributors develop comparison sheets that objectively present absorption data, CE certifications, and pricing side-by-side with TENA, allowing retail buyers to make informed decisions based on facts rather than brand familiarity alone.
Customer service infrastructure should support both existing TENA sales and the new alternative brand. Some distributors initially segment customers, introducing alternatives to new accounts while maintaining TENA for established relationships. Others offer both brands to all customers, positioning the alternative as a value tier within a comprehensive product portfolio.
Risk Mitigation and Market Entry Strategy
Prudent distributors approach TENA alternatives with a staged market entry strategy that manages risk while building market presence. A typical successful approach begins with a single container order focused on the highest-volume SKUs: medium and large pull-up pants, which represent approximately 65% of market volume. This focused entry minimizes inventory complexity while addressing the core market demand.
The initial 4-6 months function as a market testing phase, targeting 2-3 key accounts willing to trial the alternative brand with appropriate promotional support. This controlled rollout generates performance data, customer feedback, and operational learnings before broader market expansion. The 5% free goods bonus available during this phase helps fund demonstration samples and promotional activities.
Once the alternative brand demonstrates market acceptance, distributors typically expand both the product range and the account base. By month 6-9, successful distributors often place a second, larger order incorporating the full product range—tape-style diapers, underpads, and lighter pads—to serve the complete incontinence needs of their customer base. Territory exclusivity agreements become valuable at this stage, protecting the market development investment from competitive parallel distribution.
Making the Decision: Is a TENA Alternative Right for Your Distribution Business?
The decision to introduce a TENA alternative fundamentally depends on your distribution strategy and market position. Distributors with strong retail relationships, established logistics infrastructure, and the financial capacity to support a 3-6 month market entry phase typically achieve the best results. The margin enhancement of 15-25% provides meaningful financial motivation, while the growing market acceptance of quality alternatives reduces the commercial risk that existed even five years ago.
For distributors primarily serving institutional healthcare, the clinical performance specifications and unique product options (like specialized underpad sizes) often matter more than brand recognition. These segments respond to objective product data, making the transition from dominant brands to qualified alternatives more straightforward than consumer retail channels where brand familiarity influences purchasing decisions.
Ultimately, the European adult incontinence market has matured beyond single-brand dominance. Consumers and institutional buyers increasingly understand that CE certification, absorption specifications, and manufacturing quality determine product performance—not necessarily brand heritage. This market evolution creates sustainable opportunities for distributors willing to invest in educating their customer base while capturing the financial benefits of improved margin structures.
If you're exploring TENA alternatives for your distribution business, examining European-manufactured options with multi-warehouse logistics and distributor-friendly commercial terms offers a practical starting point. The combination of quality certifications, performance specifications, and margin optimization provides a foundation for profitable growth in this expanding healthcare category. Learn more about wholesale distributor programs or request product samples and pricing to conduct your own comparative evaluation.